L. Burnett, II, MD is Professor, Department of Urology, at Johns Hopkins
University School of Medicine, where he is also Director of the Basic
Science Laboratory in Neuro-urology. Currently, Dr. Burnett holds
professional appointments at the Johns Hopkins Hospital including Director
of the Male Consultation Clinic and clinician-scientist at the James
Buchanan Brady Urological Institute. Dr. Burnett received his undergraduate
degree in biology from Princeton University and subsequently his medical
degree at Johns Hopkins University School of Medicine. He then
completed his internship and residency in surgery, and subsequently residency
and fellowship in urology at the Johns Hopkins Hospital. Upon completion
of his urology residency, he also received an American Foundation of
Urologic Disease New Investigator Award to continue research work into
the regulatory mechanisms of penile erection. He has maintained
an active laboratory in neuro-urology since that time.
Burnett is an established expert in the areas of: prostate cancer;
lower genitourinary tract malignancies (penile, scrotal, and urethral
cancers); lower genitourinary tract reconstruction (pelvic trauma and
urethral stricture disease); erectile dysfunction and penile abnormalities
(including Peyronie’s disease); and female urology (including urinary
incontinence, urethral abnormalities, and prolapsed pelvic structures).
This expertise is built on academic studies regarding the surgical anatomy
of the pelvis, advances in surgical techniques of genital and pelvic
reconstructive surgery, and basic science research contributions in the
fundamental aspects of pelvic organ function.
His focus in the clinical practice of prostate cancer is reflected by
his performance of over 2,000 radical prostatectomy surgeries, his application
of a single, minimally invasive 3 inch incision just above the pubic
bone which facilitates rapid recovery and cosmesis, his application of
the “nerve-sparing” technique as described by Walsh, and
his development of management approaches to improve postoperative functional
outcomes following radical prostatectomy (see Erection
Rehabilitation after Radical Prostatectomy).
Burnett is recognized for being a world-authority in the science and
medicine of male erectile dysfunction. He contributed original
discoveries of the nitric oxide biochemical mechanisms in erectile tissue,
that paved the way for the clinical development of oral medications to
treat erectile dysfunction such as Viagra. He has also pioneered
work to develop therapies to protect penile nerve function required for
improved erectile function recovery after radical prostatectomy.
frequent contributor to the medical press, Dr. Burnett has written more
than 150 original peer-reviewed articles, along with numerous additional
articles, editorials, and book chapters, relating to his biomedical research
and clinical activities. His work has appeared in many prominent
journals such as Science, Nature Medicine, Proceedings of the National
Academy of Sciences, Journal of Urology, Urology, and Journal
of Andrology. A Fellow of the American College of Surgeons, Dr.
Burnett is also a member of the American Urological Association, Sexual
Medicine Society of North America, International Society for Sexual Medicine,
Society of Genitourinary Reconstructive Surgeons, Society for Urodynamics
and Female Urology, and the Society of Black Academic Surgeons. He
has sat on various advisory committees including the Urology Study Section,
National Institutes of Health Center for Scientific Review and FDA Advisory
Committee for Reproductive Health Drugs.